The PLAC® test is an innovative risk marker that measures the enzymatic activity of Lp-PLA2 (lipoprotein-associated phospholipase A2), a specific biomarker for vascular inflammation involved in the formation of unstable plaques that cause majority of cardiovascular events.
This easy blood test for the detection of Lp-PLA2 offers a more individual risk assessment than the usual examinations. Approximately 70% of the heart attacks and most of the strokes are caused by rupture of vascular deposits, also called atherosclerotic plaques.
Who should be tested and when?
Men ≥ 45; women ≥ 55 with at least 2 of these risk factors:
Results and Interpretation
The determination of Lp-PLA2 (a vessel-specific inflammation enzyme) shows if plaques are located within the arterial vessel wall that tend to rupture. The PLAC®-Test results allow to stratify the individual risk of a patient and adjust the treatment depending on the results.
The PLAC®-Test is a CE-labelled test.